Navigation Links
Cardiac events better treated with intense cholesterol-lowering regime

Investigators from the Weatherhead P.E.T. Center for Preventing and Reversing Atherosclerosis in Houston, Texas, United States, have suggested in a new study that intense lifestyle changes plus pharmacologic lipid treatment reduces myocardial perfusion abnormalities and cardiac events to a greater extent than usual-care cholesterol lowering drugs. They studied 409 patients with coronary artery// disease by performing myocardial perfusion imaging at baseline and after 2.6 years with software-based quantitative measurement of perfusion defects. Cardiac events were monitored during an additional five-year follow-up period.

The patients who participated in the study were divided into three categories depending on the type of treatment that was given to them. The "poor" treatment group included patients who were neither dieting nor taking lipid-lowering drugs and patients who were smoking. The "moderate" treatment group was put on the American Heart Association diet with lipid lowering drugs or a strict diet with less than 10% of calories from fat. And, the "maximal" treatment group consisted of patients who were put on strict low-fat diet, regular exercise and lipid active drugs.

Researchers, during the five-year follow-up period, found out that cardiac events occurred in 20.3% of the patients in the moderate treatment group and 30.6% of patients in the poor treatment group. In contrast, cardiac events occurred in only 6.6% of the patients in the maximal treatment group. Also, the size and severity of perfusion abnormalities decreased in the maximal treatment group but increased in both the poor and moderate treatment groups. Changes in myocardial perfusion paralleled the intensity of treatment and predicted cardiac events.


'"/>




Page: 1

Related medicine news :

1. Cardiac diseases develop early
2. Heart problems detected better with a Cardiac MRI
3. Sudden Cardiac Death due to inherited Heart Disease
4. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
5. Stem Cells From Bone Marrow Found To Improve Cardiac Functioning After A Heart Attack
6. Cardiac – Rehabilitation Programs Beneficial for Heart Patient
7. Cardiac Valve Disease Linked To Genes
8. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
9. Prevent Cardiac Problems And Laugh Your Way To Good Health
10. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
11. Glucose may support in Cardiac Arrest
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: